Gene · 1908
NIH grants1,222
NIH grants whose papers are about the gene, through NIH's grant-paper links.
221 to 240 of 1,222
Download this page as JSON| Grant | Title | EDN3 papers | Newest fiscal year |
|---|---|---|---|
| U01DK103117 | Defining the intestinal stem cell niche during organoid development into a functional human intestine | 1 | 2023 |
| U54DK104310 | Cellular and molecular mediators of fibrosis in the development of urinary tract dysfunction | 1 | 2023 |
| R01NS015547 | MICROENVIRONMENT IN ENTERIC NEURON DEVELOPMENT | 6 | 2022 |
| R01CA229215 | Dissecting the complexity of metastasis with mathematical models and quantitative experiments with in zebrafish | 5 | 2022 |
| R01NS104573 | Progressive Post Stroke Cognitive Impairment:Mechanisms & Intervention | 3 | 2022 |
| K00CA223016 | Investigating cancer metabolism and its potential for therapeutic intervention | 2 | 2022 |
| P20GM104357 | Cardiorenal and Metabolic Diseases Research Center | 2 | 2022 |
| R01AG062348 | The Contribution of Age-Related Tauopathies to Alzheimer's Disease | 2 | 2022 |
| R01DC012115 | Implementing genomic medicine in clinical care of deaf patients | 2 | 2022 |
| RF1NS083559 | Vascular Injury and Recovery in Diabetic Ischemic Stroke | 2 | 2022 |
| U54HL141981 | Unraveling the immune response to factor VIII | 2 | 2022 |
| ZIADC000060 | Molecular Analysis Of Human Hereditary Deafness | 2 | 2022 |
| F30CA236442 | Investigating the Role of Adipocyte Lipolysis in Melanoma Progression | 1 | 2022 |
| F31AG067709 | Loss of nuclear integrity is sufficient to induce age-associated changes and Alzheimer's pathology in hPSC-derived cortical neurons. | 1 | 2022 |
| F32HL158011 | Vascular Contributions to Enriched Rehabilitation in Hypertension | 1 | 2022 |
| I01BX000574 | Autocrine/Paracrine Regulation of Intrahepatic Bile Duct Growth | 1 | 2022 |
| I01CX001038 | The neuropathology of mild traumatic brain injury in Alzheimer disease | 1 | 2022 |
| K00NS105182 | Regulation of Degradative Pathways in Tauopathies | 1 | 2022 |
| K08HL140178 | Mechanistic evaluation of a novel Wnt-responsive adult alveolar epithelial progenitor population during regeneration after diffuse alveolar damage | 1 | 2022 |
| K23NS102399 | Repetitive Head Impact Exposure and Later-Life White Matter Signal Abnormalities: An Investigation in Former NFL Players, Subjects with Alzheimer's Disease, and Cognitively Normal Controls | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1908/grants?page=12